Anastrozole CAS:120511-73-1 Manufacturer Supplier

Anastrozole is a non-steroidal and expensive drug marketed under the trade name Arimidex. It was the first specific aromatase inhibitor approved in theUnited States. It is indicated for first-line treatment of postmenopausalwomen with advanced or metastatic breast cancer,for second-line treatment of postmenopausal patientswith advanced breast cancer who have had disease progressionfollowing tamoxifen therapy, and for adjuvant treatmentof women with early breast cancer. Patients who did not respondto tamoxifen therapy rarely respond to anastrozole.

Products Details

Application and Effect

Anastrozole is a nonsteroidal inhibitor of aromatase which effectively blocks estrogen synthesis in postmenopausal women and is used as therapy of estrogen receptor positive breast cancer. Anastrozole has been associated with a low rate of serum enzyme elevations during therapy and rare instances of clinically apparent liver injury.Anastrozole is a highly potent and selective aromatase inhibitor. It is extremely potent in lowering circulating estradiol to undetectable levels in treated patients without altering other circulating hormones. The drug is reportedly well absorbed and tolerated following oral administration.

Product Sample

Product Packing:

Additional Information:

Composition C17H19N5
Assay 99%
Appearance White powder
CAS No. 120511-73-1
Packing 1KG 25KG
Shelf Life 2 years
Storage Store in cool and dry area
Certification ISO.

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours